News

Is the FDA doing enough to incorporate the patient perspective in the drug review process?

AVERT Delivers Proven and Efficient Solution for Broad Assessment of Suicide Risk

The State of Oklahoma, Department of Mental Health and Substance Abuse Services will be implementing ERT's AVERT Suicide Risk Assessment

The mounting outrage over exorbitant prices for new medicines increases the importance of reducing the cost of biomedical product development.

An article that sets the stage for why improvements in the contract negotiations with sites has and needed to improve for the past two years.

Patient consent is important to stay on top of for many reasons.

The report of a joint initiative by the EMA and the EUnetHTA has been published.

The report of an initiative undertaken jointly by EMA and EUnetHTA to make regulators' reports about scientific assessments of medicines better usable by health technology assessment bodies, has been published.

More than three million NHS patients in England have taken part in research studies over the last six years supported by the National Institute for Health Research Clinical Research Network.

More than three million National Health Service patients in England have participated in research studies over the last six years.

RAPS has released the results of its biennial survey of the global healthcare regulatory profession.

The advent of Accountable Care Organizations is causing providers to rethink their legacy financial models as they seek to effectively quantify and understand the clinical or financial experience of their patients.

RAPS has released the results of its biennial survey of the global healthcare regulatory profession.

DIA held its 2014 annual meeting in San Diego and attracted thousands of attendees from around the globe.

Children and young people should routinely be offered the opportunity to participate in and to benefit from medical research.

As the new European Parliament assembles for the start of its five-year term on July 1, many familiar faces will be missing.

Amid all the heated discussions of transparency and the insistence on ever wider disclosure, an intriguing contrast is provided by a document signed by health ministers on June 20.

May be time to review current restrictive guidance in UK and elsewhere

Prisoners are being unfairly excluded from taking part in potentially beneficial clinical research, on the grounds that it would be too difficult and expensive to include them...

This is the third post in a three-part series on quality implications of RBM.

We got the chance to speak with Nancy Dreyer, chief of scientific affairs and senior VP at Quintiles Outcome about the current tide for comparative effectiveness research

Debuting at BIO, Covance MarketPlace Connects Emerging Biotech with Potential Partners Early in the Development Process

Covance announced the introduction of Covance MarketPlace, a new solution that enables Covance?s emerging biotechnology and established pharmaceutical clients to find and forge new partnerships in a secure forum.

Progress on new research and treatments for dementia has been "achingly slow," noted Dennis Gillings, PhD, Executive Chairman of Quintiles.

IMS Health

Benchmark Research is the latest participant in the Association of Clinical Research Professionals' Certification Supporting Partner Program.

Alliance will rapidly expand sponsors and CROs access to advanced predictive, implementation, and operations support technologies

ACRP and the European Centre for Clinical Research Training announce the introduction of the ECCRT/ACRP STAR Program.

Privacy Analytics, Inc. announced the availability of a new solution designed to enable pharmaceutical companies to share clinical trials data while protecting the privacy of the individual patients.

agCapture 3.2 Delivers on the Promise of Real Unification of Data Management Processes